Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

Discover an awarding winning abstract from EASL 2025 that has called for more person-centred hepatitis screening. Learn more.

A global study suggests that using small molecule inhibitors followed by epigenetic modifiers may significantly improve ...

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 ...

New analysis shows promising repigmentation with JAK inhibitors in vitiligo, especially in combination with UVB. Safety and ...

CHRONIC LIVER diseases, such as alcoholic, viral, autoimmune, and metabolic liver disorders, often progress to fibrosis and ...

Swiss researchers use DXA data and machine learning to predict fracture risk in women, with logistic regression delivering ...

Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.

From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.

New research explores how virus-specific T-cell therapy may help prevent or treat cytomegalovirus after transplant, revealing high response rates in HSCT patients but limited data in solid organ ...

To evaluate the therapeutic value of mirikizumab in IBD, researchers conducted a systematic review and meta-analysis of ...

New SEER data presented at AACR 2025 reveal a sharp decline in breast cancer mortality among women aged 20 to 49 across all ...